Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 4, 2007, Pages 975-977

  Martin, Ludovic ^a,b   Raison Peyron, Nadia ^b,c   Nöthen, Markus M ^d   Cichon, Sven ^d   Drouet, Christian ^b,e  

^a Orléans Hospital   (France)

^b French Reference Center for Angioedema   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF BONN   (Germany)

^e UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ESTROGEN; KALLIKREIN; TRANEXAMIC ACID;

ANGIONEUROTIC EDEMA; DNA EXTRACTION; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC DISORDER; HUMAN; LETTER; MALE; POINT MUTATION; PREGNANCY; PRIORITY JOURNAL; SEX DIFFERENCE;

ANGIONEUROTIC EDEMA; COMPLEMENT C1 INHIBITOR PROTEIN; FACTOR XII; FEMALE; HUMANS; MALE; MUTATION; PEDIGREE;

EID: 34948849184     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.07.002     Document Type: Letter

References (11)

1. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the Third C1 Esterase Inhibitor Deficiency Workshop and beyond. J Allergy Clin Immunol 114 (2004) S51-S131
2. Bork K., Barnstedt S.E., Koch P., and Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356 (2000) 213-217
3. Binkley K.E., and Davis A. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106 (2000) 546-550
4. Martin L., Degenne D., Toutain A., Ponard D., and Watier H. Hereditary angioedema type 3: an additional French pedigree with autosomal dominant transmission. J Allergy Clin Immunol 107 (2001) 747-748
5. Cichon S., Martin L., Hennies H.C., Müller F., van Driesche K., Karpushova A., et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79 (2006) 1098-1104
6. Farsetti A., Misiti S., Citarella F., Felici A., Andreoli M., Fantoni A., et al. Molecular basis of estrogen regulation of the Hageman factor XII gene expression. Endocrinology 136 (1995) 5076-5083
7. Cicardi M., Bergamaschini L., Zingale L.C., Gioffré D., and Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 106 (1999) 650-654
8. Cicardi M., and Zingale L. Clinical manifestations of HAE. J Allergy Clin Immunol 114 (2004) S55-S61
9. Drouet C., Blanch A., Roche O., Monnier N., Duponchel C., Kalmar L., et al. HAE: genetic investigations. J Allergy Clin Immunol 114 (2004) S65-S74
10. Bork K., Gül D., and Dewald G. Hereditary angioedema with normal C1-inhibitor in a family with affected women and men. Br J Dermatol 154 (2005) 542-545
11. Gupta S., Yu F., and Klaustermeyer W.B. New variant hereditary angioedema in three brothers with normal C1 esterase inhibitor level and function. Allergy 59 (2004) 557-558